Tag Archives: Global

Indian Government Proposes Ban on Physician Gifts

India’s Department of Pharmaceuticals released a 14-page “voluntary code” for drug marketers, which includes a strict ban on gifts to prescribers, among other things. The code, which is open for public comment until June 30th, states that “no gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised to persons qualified to […]
Posted in Advertising, Emerging Markets, Global, Marketing, Medical Education, Strategy | Also tagged , , , , , | Leave a comment

California Life Sciences to Partner with China

BIOCOM, a trade group representing Southern California’s life sciences industry, is ramping up partnership efforts in China to meet an emerging desire for novel drug therapies. While intellectual property (IP) protections and the Chinese government’s willingness to pay for expensive new products represent two large and lingering question marks, Joe Panetta, president and CEO at […]
Posted in Biotech, Emerging Markets, Global, IP, leadership, Market Access, R&D | Also tagged , , , | Leave a comment

Fixing Biotech's Broken Business Model

Despite some notable successes, the global biotech industry has fallen short of expectations. Strategic collaborations have been on the increase, but there is now a need for more co-operation using new collaboration models, writes Jo Pisani. The current business model on which biotech has relied is flawed. Due to poor rates of return, investment has […]
Posted in Biotech, Deals, Emerging Markets, Europe, Global, Guest Blog, R&D | Also tagged , , , , , , , | Leave a comment

Ireland's Economic Bailout to Sting Pharma

Ireland’s favorable level of corporation tax remains untouched by the country’s economic rescue package, but drugmakers will still feel the pinch of the healthcare cuts. Despite pressure from France and Germany, Ireland has managed to secure its Euro 85 billion ($111 billion) rescue package from Europe and the International Monetary Fund without raising corporation tax, […]
Posted in Europe, Global, Regulatory | Also tagged , , , , | Leave a comment

Big Pharma Reps Still Competing with Local Players in Emerging Markets

Although pharma is an increasingly global marketplace, the relative rankings of companies are becoming more localized — with significant variations — according to a new Cegedim survey of physician attitudes towards reps in the major western markets and Brazil, India, Russia, and China. According to the International Rep Quality survey, physicians tend to favor domestic […]
Posted in Emerging Markets, Europe, Guest Blog, Marketing, Sales | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta